My hunch is it is to do with XV Ventilation (XV) FDA approval forward from it's clearance in Mar 2020 OR maybe a early TGA pre submission update OR maybe regulatory approval in another part of the world. However I'm a bit confused as 4dx is implementing a SaaS model rather than an actual "medical device" as such.
Unless someone can shed more light around this space.
Ann: Trading Halt, page-6
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
57.5¢ |
Change
0.045(8.49%) |
Mkt cap ! $223.7M | |||
| Open | High | Low | Value | Volume |
| 53.5¢ | 57.5¢ | 53.0¢ | $455.7K | 823.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 36519 | 57.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 57.5¢ | 235 | 1 |
View Market Depth
| Last trade - 11.53am 08/10/2024 (20 minute delay) ? |
| 4DX (ASX) Chart |